Tirzepatide : The latest advancement in GLP-1 agonist therapy, Tirzepatide combines the benefits of GLP-1 with GIP (glucose-dependent insulinotropic polypeptide), another hormone involved in blood sugar regulation
Semaglutide is a synthetic medication engineered to mimic GLP-1's effects while remaining active for approximately 7 days, enabling practical once-weekly dosing
Chen, X.-F., Wang, L., Wu, Y.-Z., Song, S.-Y., Min, H.-Y., & Yang, Y
Perkovic, V., et al
It is commonly referenced in preclinical and laboratory research examining cellular metabolism and enzyme-associated biochemical pathways within controlled research systems
Yet, despite their ability to sustain energetics and functionality in critical tissues, animals subjected to this fasting-refeeding cycle displayed lasting physiological changes, including a reduction in body size that persisted well into later life (Supplementary Fig